Leprosy Elimination Programme MCQ Quiz | National Health Programmes

Welcome to this specialized quiz on the National Leprosy Eradication Programme (NLEP), designed for MBBS students preparing for their examinations. This quiz will test your understanding of the key strategies, diagnostic criteria, treatment protocols (MDT), and public health goals associated with leprosy elimination in India. Covering 25 multiple-choice questions, this assessment delves into paucibacillary and multibacillary classifications, disability prevention, and recent programmatic updates. A strong grasp of NLEP is crucial for community medicine. After submitting your answers, you will receive your score and see the correct responses highlighted. You can also download a PDF copy of all questions with their correct answers for your revision. Good luck!

1. What is the defined prevalence rate for the “elimination of leprosy as a public health problem” under the NLEP?

2. According to NLEP guidelines, Paucibacillary (PB) leprosy is defined as:

3. What is the standard duration of Multi-Drug Therapy (MDT) for an adult with Multibacillary (MB) leprosy?

4. The adult MDT regimen for Paucibacillary (PB) leprosy consists of:

5. Which of the following is NOT a cardinal sign of leprosy?

6. The “SPARSH Leprosy Awareness Campaign” is observed every year on which date?

7. DPMR under NLEP stands for:

8. Which drug is administered as Post-Exposure Prophylaxis (PEP) for contacts of leprosy patients?

9. A WHO Grade 2 Disability in a leprosy patient implies:

10. Which healthcare worker plays a pivotal role in early case detection and ensuring treatment completion at the village level under NLEP?

11. The primary target cells of *Mycobacterium leprae* are:

12. Which of the following drugs in MDT is most rapidly bactericidal against *M. leprae*?

13. The main strategy for case detection under NLEP is:

14. Which statement is TRUE for Multibacillary (MB) leprosy classification?

15. The causative agent of leprosy, *Mycobacterium leprae*, was discovered by:

16. Which of the following is the most common mode of transmission for leprosy?

17. Lepra reactions (Type 1 and Type 2) are primarily managed with which class of drugs?

18. The National Leprosy Eradication Programme (NLEP) is a centrally sponsored scheme under which umbrella program?

19. What is the main purpose of providing Micro-cellular rubber (MCR) footwear to leprosy patients?

20. In the MDT regimen for MB leprosy, what is the role of Clofazimine?

21. The “Modified Leprosy Elimination Campaign” (MLEC) primarily focused on:

22. What is the recommended duration of treatment for Paucibacillary (PB) leprosy in adults?

23. Which of these is a characteristic of Type 2 Lepra Reaction (Erythema Nodosum Leprosum)?

24. A key objective of NLEP’s information, education, and communication (IEC) activities is to:

25. A patient is considered “Released From Treatment” (RFT) after: